Physiological Regulation and Disorders of Phosphate Metabolism -Pivotal Role of Fibroblast Growth Factor 23-
スポンサーリンク
概要
- 論文の詳細を見る
Fibroblast growth factor (FGF) 23 has been identified as the last member of FGF family. FGF23 reduces serum phosphate level by suppressing proximal tubular phosphate reabsorption and intestinal phosphate absorption. FGF23 is produced by bone and acts on the kidney through a specific receptor system which is composed of Klotho and certain subtypes of FGF receptors. Excess actions of FGF23 cause several hypophosphatemic diseases characterized by impaired renal phosphate reabsorption and rickets/osteomalacia. In contrast, deficient actions of FGF23 result in hyperphosphatemic tumoral calcinosis with enhanced renal phosphate reabsorption. These results indicate that FGF23 works as a hormone to regulate the serum phosphate level.
- 社団法人 日本内科学会の論文
著者
-
Fukumoto Seiji
Division Of Nephrology & Endocrinology Department Of Internal Medicine University Of Tokyo Hospi
-
Fukumoto Seiji
Division of Nephrology and Endocrinology, Department of Internal Medicine, University of Tokyo Hospital
関連論文
- A novel mutation in the GATA3 gene of a Japanese patient with PTH-deficient hypoparathyroidism
- Causes and Differential Diagnosis of Hypocalcemia : Recommendation Proposed by Expert Panel Supported by Ministry of Health, Labour and Welfare, Japan
- Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans
- Comparison of two assays for fibroblast growth factor (FGF)-23
- Tumor-Induced Hypophosphatemic Osteomalacia Diagnosed by the Combinatory Procedures of Magnetic Resonance Imaging and Venous Sampling for FGF23
- Actions and Mode of Actions of FGF19 Subfamily Members
- Development of Tumor-induced Osteomalacia in a Subcutaneous Tumor, Defined by Venous Blood Sampling of Fibroblast Growth Factor-23
- Fibroblast growth factor 23 as a phosphotropic hormone and beyond
- Physiological Regulation and Disorders of Phosphate Metabolism -Pivotal Role of Fibroblast Growth Factor 23-
- Evaluation of a new automated chemiluminescence immunoassay for FGF23